BGMS - Cyclacel Pharmaceuticals, Inc.
0.95
-0.010 -1.063%
Share volume: 18,854
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$0.96
-0.01
-0.01%
Summary score
21%
Profitability
25%
Dept financing
4%
Liquidity
50%
Performance
15%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-14.87%
Return on assets
-12.75%
Return on sales
0%
Return on invested capital
161.84%
Total debt ratio
20.3%
Debt ratio change over timeo
0%
Current Ratio
6.54%
Quick Ratio
0%
Cash Position Ratio
5.87%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-13.69%
Return on assets
-14.78%
Return on sales
0%
Return on invested capital
404.58%
Total debt ratio
17.84%
Debt ratio change over timeo
0%
Current Ratio
9.92%
Quick Ratio
0%
Cash Position Ratio
8.45%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-8.34%
Return on assets
-8.47%
Return on sales
0%
Return on invested capital
808.76%
Total debt ratio
8.89%
Debt ratio change over time
0%
Current Ratio
18.47%
Quick Ratio
0%
Cash Position Ratio
16.76%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BGMS | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -14.87% | 17.45% | 4.69% | -3.05% |
| Return on assets | -12.75% | 3.37% | 3.35% | 3.6% |
| Return on sales | 0% | 23.96% | 25.96% | 32.14% |
| Return on invested capital | 161.84% | 5.2% | 4.37% | 5.09% |
| Profitability | 25% | 68% | 51% | 51% |
| Total debt ratio | 20.3% | 77% | 57.66% | 101.18% |
| Debt ratio change over time | 0% | 0% | 10.55% | 69.81% |
| Dept financing | 5% | 19% | 18% | 50% |
| Current Ratio | 9.92% | 1.16% | 1.27% | 2.08% |
| Quick Ratio | 0% | 0.89% | 1.01% | 1.96% |
| Cash Position Ratio | 8.45% | 0.17% | 0.53% | 1.48% |
| Liquididy | 50% | 26% | 33% | 34% |
| Short-term ratios | BGMS | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -13.69% | 44.06% | 6.24% | -25.62% |
| Return on assets | -14.78% | 3.88% | 3.22% | 3.26% |
| Return on sales | 0% | 27.04% | 24.93% | 31.22% |
| Return on invested capital | 404.58% | 9.69% | 4.96% | 8.14% |
| Profitability | 25% | 72% | 45% | 47% |
| Total debt ratio | 17.84% | 91.8% | 61.39% | 105.33% |
| Debt ratio change over time | 0% | 0% | 12.93% | 15.97% |
| Dept financing | 4% | 22% | 35% | 50% |
| Current Ratio | 9.92% | 1.16% | 1.27% | 2.08% |
| Quick Ratio | 0% | 0.89% | 1.01% | 1.96% |
| Cash Position Ratio | 8.45% | 0.17% | 0.53% | 1.48% |
| Liquididy | 50% | 15% | 18% | 35% |